Cost-Effectiveness of Prostate Radiation Therapy in Men with Newly Diagnosed Low Burden Metastatic Prostate Cancer

被引：0
|
作者：
Lester-Coll, N. H. [1 ]
Ades, S. [2 ]
Yu, J. B. [3 ]
Atherly, A. [4 ]
Wallace, H. J. [1 ]
Sprague, B. L. [5 ]
机构：
[1] Univ Vermont, Larner Coll Med, Div Radiat Oncol, Burlington, VT USA
[2] Univ Vermont, Larner Coll Med, Div Hematol & Oncol, Burlington, VT USA
[3] Yale Sch Med, Dept Therapeut Radiol, New Haven, CT USA
[4] Univ Vermont, Dept Med, Larner Coll Med, Burlington, VT USA
[5] Univ Vermont, Dept Surg, Larner Coll Med, Burlington, VT 05405 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2019.06.221
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1141
引用
收藏
页码：S180 / S181
页数：2
相关论文
共 50 条
  • [1] Cost-effectiveness of Prostate Radiation Therapy for Men With Newly Diagnosed Low-Burden Metastatic Prostate Cancer
    Lester-Coll, Nataniel H.
    Ades, Steven
    Yu, James B.
    Atherly, Adam
    Wallace, H. James, III
    Sprague, Brian L.
    JAMA NETWORK OPEN, 2021, 4 (01)
  • [2] Cost-effectiveness of Prostate Radiation Therapy for Men With Newly Diagnosed Low-Burden Metastatic Prostate Cancer (vol 4, e2033787, 2021)
    Lester-Coll, N. H.
    Ades, S.
    Yu, J. B.
    Atherly, A.
    Wallace, H. J., III
    Sprague, B. L.
    JAMA NETWORK OPEN, 2021, 4 (02)
  • [3] Cost-effectiveness Analysis of Innovative Therapy for Patients with Newly Diagnosed Hormone-Sensitive Metastatic Prostate Cancer
    Pelloux-Prayer, Remi
    Schiele, Philomene
    Oudard, Stephane
    Gravis, Gwenaelle
    Kleinclauss, Francois
    Crehange, Gilles
    Hennequin, Christophe
    Morgans, Alicia K.
    Geoffrois, Lionel
    Limat, Samuel
    Thiery-Vuillemin, Antoine
    Nerich, Virginie
    CLINICAL GENITOURINARY CANCER, 2021, 19 (05) : E326 - E333
  • [4] COST-EFFECTIVENESS ANALYSIS OF INNOVATIVE THERAPY FOR PATIENTS WITH NEWLY DIAGNOSED HORMONE-SENSITIVE METASTATIC PROSTATE CANCER
    Pelloux-Prayer, R.
    Schiele, P.
    Oudard, S.
    Gravis, G.
    Kleinclauss, F.
    Crehange, G.
    Hennequin, C.
    Morgans, A.
    Geoffrois, L.
    Limat, S.
    Thiery-Vuillemin, A.
    Nerich, V
    VALUE IN HEALTH, 2022, 25 (01) : S113 - S113
  • [5] Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer
    Rusthoven, Chad G.
    Jones, Bernard L.
    Flaig, Thomas W.
    Crawford, E. David
    Koshy, Matthew
    Sher, David J.
    Mahmood, Usama
    Chen, Ronald C.
    Chapin, Brian F.
    Kavanagh, Brian D.
    Pugh, Thomas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (24) : 2835 - +
  • [6] Survival modelling and cost-effectiveness analysis of treatments for newly diagnosed metastatic hormone-sensitive prostate cancer
    Barbier, Michaela C.
    Tomonaga, Yuki
    Menges, Dominik
    Yebyo, Henock G.
    Haile, Sarah R.
    Puhan, Milo A.
    Schwenkglenks, Matthias
    PLOS ONE, 2022, 17 (11):
  • [7] Prostate radiotherapy in newly diagnosed metastatic prostate cancer
    Ali, Adnan
    Parker, Christopher C.
    Clarke, Noel W.
    CURRENT OPINION IN UROLOGY, 2019, 29 (06) : 620 - 628
  • [8] Multidisciplinary Therapy in Men with Newly Diagnosed Oligometastatic Prostate Cancer
    Watanabe, Kazuhiro
    Kawaguchi, Gen
    Ikeda, Yohei
    Hara, Noboru
    Nishiyama, Tsutomu
    RESEARCH AND REPORTS IN UROLOGY, 2021, 13 : 565 - 571
  • [9] Survival in men with newly diagnosed hormone sensitive metastatic prostate cancer
    Stroomberg, H. V.
    Helgstrand, J. T.
    Brasso, K.
    Roder, A.
    EUROPEAN UROLOGY, 2023, 83
  • [10] The cost-effectiveness of prostate health index for prostate cancer detection in Chinese men
    Teoh, Jeremy Yuen Chun
    Chiu, Peter Ka Fung
    Yip, Siu Ying
    Yee, Chi Hang
    Li, Suk Yin
    Ng, Chi Fai
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 : 342 - 342
12345